• Adaptive Biotechnologies Chief People Officer Francis Lo sold 105,762 shares on July 15 at a weighted average USD 22.59.
• Lo also exercised stock options for 105,762 shares at USD 7.8, USD 12.14, USD 8.46.
• Directly held common stock fell to 230,713 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780660-26-000019), on July 17, 2026, and is solely responsible for the information contained therein.